Ocular involvement in Wegener's granulomatosis responding to intravenous cyclophosphamide [3]

Rheumatology

Volumn 40, Issue 9, 2001, Pages 1066-1068

  Cuende, E ^a   Ruiz Mena, A ^a   Andonegui, J ^a   Minguela, I ^a   Vesga, J C ^b  

^a HOSPITAL TXAGORRITXU   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; METHOTREXATE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE;

ADULT; CASE REPORT; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; GLOMERULONEPHRITIS; HUMAN; INFECTION; LETTER; LUNG HEMORRHAGE; MALE; OPHTHALMOSCOPY; PANCYTOPENIA; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; RETINA VASCULITIS; VISUAL ACUITY; WEGENER GRANULOMATOSIS;

EID: 0034794731     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/40.9.1066     Document Type: Letter

References (9)

1. Wegener granulomatosis: An analysis of 158 patients
2. An interdisciplinary approach to the care of patients with Wegener's granulomatosis
3. Wegener's granulomatosis
4. Disease relapse in patients with ocular manifestations of Wegener granulomatosis
5. Ocular complications of Wegener's granulomatosis
6. Ocular changes in limited forms of Wegener's granulomatosis
7. The ocular manifestation's of Wegener's granulomatosis
8. A prospective, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis
9. An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone